Intramuscular administration of influenza hemagglutinin in one hind leg elicits similar protective immune responses as administration in two hind legs. [PDF]
Uno N, Ross TM.
europepmc +1 more source
Influenza A(H3N2) Subclade K: Epidemiology, Molecular Evolution and Vaccine Effectiveness in Europe. [PDF]
Scarvaglieri I +7 more
europepmc +1 more source
Receptor-binding specificity and antigenic properties of a genotype D1.1 A(H5N1) influenza virus isolated from a human. [PDF]
Kandeil A +11 more
europepmc +1 more source
From Phage Display to Yeast Secretion: Developing Fc-Fused Nanobodies Against Influenza Virus. [PDF]
Wang M +10 more
europepmc +1 more source
Detection of Avian Influenza H5-Specific Antibodies by Chemiluminescent Assays. [PDF]
Márquez AC +5 more
europepmc +1 more source
Expanding Horizons: Host Range Evolution and Treatment Strategies for Highly Pathogenic Avian Influenza H5N1 and H7N9. [PDF]
Gazik NH, Holodniy M, Bayat V.
europepmc +1 more source
AI-Powered Identification of Human Cell Surface Protein Interactors of the Hemagglutinin Glycoprotein of High-Pandemic-Risk H5N1 Influenza Virus. [PDF]
Poitras C, Coulombe B.
europepmc +1 more source
Influenza A(H3N2) Subclade K (J.2.4.1): Molecular Characterization, Antigenic Divergence, and Global Spread During the 2025/26 Season. [PDF]
Branda F +5 more
europepmc +1 more source
The influenza B virus candidate vaccine expressing H3 hemagglutinin developed in suspension MDCK cells confers protection against lethal H3N2 avian influenza in BALB/c mice. [PDF]
Wu Y +8 more
europepmc +1 more source
Scalable secretory production of influenza A (H1N1) hemagglutinin HA1 in Pichia pastoris through expression and process optimization. [PDF]
Guo Z +6 more
europepmc +1 more source

